Needle displacement during high-dose-rate afterloading brachytherapy boost and conventional external beam radiation therapy for initial and local advanced prostate cancer

Urologia Internationalis

Volumn 70, Issue 3, 2003, Pages 200-204

  Pellizzon, A C A ^a   Salvajoli, J V ^a   Novaes, P E R S ^a   Maia, M A C ^a   Ferigno, R ^a   Fogaroli, R C ^a  

^a A C CAMARGO CANCER CENTER   (Brazil)

Author keywords

Biochemical control; High dose rate afterloading brachytherapy; Prostate cancer; Quality control

Indexed keywords

ADULT; ADVANCED CANCER; AGED; ARTICLE; BIOCHEMISTRY; BRACHYTHERAPY; CANCER STAGING; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; EXTERNAL BEAM RADIOTHERAPY; FOLLOW UP; HUMAN; MALE; NEEDLE DISPLACEMENT; PELVIS; PRIORITY JOURNAL; PROSTATE CANCER; RADIATION DOSE; RADIATION INJURY; TUMOR VOLUME;

ADENOCARCINOMA; AGED; BRACHYTHERAPY; FOLLOW-UP STUDIES; HUMANS; MALE; PROSTATIC NEOPLASMS; RADIOTHERAPY DOSAGE; RADIOTHERAPY, HIGH-ENERGY; TIME FACTORS;

EID: 0037242369     PISSN: 00421138     EISSN: None     Source Type: Journal    
DOI: 10.1159/000068775     Document Type: Article

References (19)

1. Brasil: Ministério da Saúde, Secretaria Nacional de Assistência à Saúde, Instituto nacional do cancer. Estimativa de incidência e mortalidade por câncer no Brasil 2001. Rio de Janeiro, INCA, 2000, p 23.
2. Landis SH, Murray T, Bolden S, Wingo PA: Cancer statistics, 1999. CA Cancer J Clin 1999;49:8-31.
3. Pilepich MV, Bagshaw MA, Asbell SO, Hanks GE, Krall JM, Emami BN, Bard RH: Radical prostatectomy or radiotherapy in carcinoma of prostate: The dilemma continues. Urology 1987;30:18-21.
4. American Cancer Society: Cancer Facts and Figures. Atlanta, American Cancer Society, 1997.
5. Zelefsky MJ, Leibel SA, Gaudin PB, Kutcher GJ, Fleshner NE, Venkatramen ES, Reuter VE, Fair WR, Ling CC, Fuks Z: Dose escalation with three-dimensional conformal radiation therapy affects the outcome in prostate cancer. Int J Radiat Oncol Biol Phys 1998;41:491-500.
6. Lee AK, Schultz D, Renshaw A, Richie J, D'Amico AV: Optimizing patient selection for prostate monotherapy. Int J Radiat Oncol Biol Phys 2001;49:673-677.
7. Kestin LL, Martinez AA, Stromberg JS, Edmundson GK, Gustafson GS, Brabbins DS, Chen PY, Vicini FA: Matched-pair analysis of conformal high-dose-rate brachytherapy boost versus external-beam radiation therapy alone for locally advanced prostate cancer. J Clin Oncol 2000;18:2869-2880.
8. Hanks GE, Schultheiss TE, Hanlon AL, Hunt M, Lee WR, Epstein BE, Coia LR: Optimization of conformal radiation treatment of prostate cancer: Report of a dose escalation study. Int J Radiat Oncol Biol Phys 1997;37:543-550.
9. Marks LB, Anscher MS: Radiotherapy for prostate cancer: Should the seminal vesicles be considered target? Int J Radiat Oncol Biol Phys 1992;24:435-440.
10. Hanks GE, Lee WR, Hanlon AL, Hunt M, Kaplan E, Epstein BE, Movsas B, Schultheiss TE: Conformal technique dose escalation for prostate cancer: Biochemical evidence of improved cancer control with higher doses in patients with pretreatment prostate-specific antigen > or = 10 ng/ml. Int J Radiat Oncol Biol Phys 1996;35:861-868.
11. Pollack A, Zagars GK: External beam radiotherapy dose response of prostate cancer. Int J Radiat Oncol Biol Phys 1997;39:1011-1018.
12. Zelefsky MJ, Leibel SA, Kutcher GJ, Fuks Z: Three-dimensional conformal radiotherapy and dose escalation: Where do we stand? Semin Radiat Oncol 1998;8:107-114.
13. Pollack A, Smith LG, von Eschenbach AC: External beam radiotherapy dose response characteristics of 1,127 men with prostate cancer treated in the PSA era. Int J Radiat Oncol Biol Phys 2000;48:507-512.
14. 125I prostate implant: A case study. Int J Radiat Oncol Biol Phys 1997;38:335-339.
15. Martinez AA, Pataki I, Edmundson G, Sebastian E, Brabbins D, Gustafson G: Phase II prospective study of the use of conformal high-dose-rate brachytherapy as monotherapy for the treatment of favorable stage prostate cancer: A feasibility report. Int J Radiat Oncol Biol Phys 2000;49:61-69.
16. Mate TP, Gottesman JE, Hatton J, Gribble M, Van Hollebeke L: High-dose-rate afterloading iridium-192 prostate brachytherapy: Feasibility report. Int J Radiat Oncol Biol Phys 1998;41:525-533.
17. Damore SJ, Syed N, Puthawala AA, Sharma A: Needle displacement during HDR brachytherapy in the treatment of prostate cancer. Int J Radiat Oncol Biol Phys 2000;46:1205-1211.
18. Blasko JC, Wallner K, Grimm PD, Ragde H: Prostate-specific antigen-based disease following ultrasound-guided iodine-125 implantation of stage T1/T2 prostatic carcinoma. J Urol 1995;154:1096-1099.
19. Ragde H, Blasko JC, Grimm PD, Kenny GM, Sylvester J, Hoak DC, Cavanagh W, Landin K: Brachytherapy for clinically localized prostate cancer: Results at 7- and 8-year follow-up. Semin Surg Oncol 1997;13:438-443.